Hepatitis C infection in risk groups
Authors:
Open Access
- 20 November 2006
- journal article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 6 (4) , 13-17
Abstract
Hepatitis C infection is important global health problem with wide spectrum of health, social and economic consequences. The goal of this research was to estimate prevalence of hepatitis C virus infection in risk groups, and to determine association hepatitis C virus (HCV) infection and risk factors. Research included 4627 subjects divided in two groups. Test group included 2627 subjects divided in 4 subgroups with risk for HCV infection: those who received blood transfusion without screening on HCV (it was introduced in 1995) (700); intravenous drug users (60); patients on hemodialysis (168) and health care workers (1699). Control group included 2000 healthy volunteer blood donors. In all subjects anti-HCV antibodies were tested with third generation ELISA test. Positive serum samples were tested for presence of HCVRNA, using reaction of reverse transcription and polymerase chain reaction. In all anti-HCV positive subjects further epidemiological and clinical workup was performed. Prevalence of HCV infection in risk groups was: 4.6% in subjects who have received blood transfusions without HCV blood screening, 35% in intravenous drug users, 58.9% in patients on chronic dialysis, and 0.4% in health care workers. In control group prevalence was low (0.2%). In the group of 158 anti-HCV positive subjects, 73.4% had HCVRNA. The largest number of subjects with HCV infection was in the age group of 30-49 years (45.8%). This study showed that multiple blood transfusions before introducing the blood screening for HCV, longer duration of intravenous drug abuse, longer duration of hemodialysis treatment, larger number of accidental injuries in health care workers are independent and statistically significant risk factors for those groups examined. Results of this study confirm that general screening for HCV infection is recommended in risk groups for HCV infection in order to identify to prevent and to treat it.Keywords
This publication has 8 references indexed in Scilit:
- Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000Intervirology, 2004
- Estimating future hepatitis C morbidity, mortality, and costs in the United StatesAmerican Journal of Public Health, 2000
- Epidemiology of hepatitis C in the United StatesThe American Journal of Medicine, 1999
- Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune GlobulinNew England Journal of Medicine, 1999
- Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.1998
- Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groupsDigestive Diseases and Sciences, 1996
- High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalenceJournal of Clinical Microbiology, 1996
- Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmissionKidney International, 1996